WESTMINSTER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO) today announced that it has retained Ladenburg Thalmann & Co. Inc. to act as its financial advisor.
ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here